Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
It is beyond my comprehension that punters can’t sit on their hands for a couple of weeks.
I am convinced that the investor presentation will be positive and there will be an upward revision in the share price.
As I have observed several times in the passed most PI’s never make a profit because they never buy or sell at the right time.
For the avoidance of doubt I bought a significant number of share in the placement at 7p. I could have tried to trade but resisted.Not trusting my timing.
I am waiting for the buyout that will surely come.
If the fickle IP’s don’t get a new RNS every other day they panic and sell.Its really pathetic
Make no mistake this news is massive. For it to be available on prescription it would have to have gone through the NICE process.
This will be free to those over 60.
Moreover it will be prescribed for those who are counter indicated for other treatments for ED.
I have commented many times about this share being traded,and that’s why it cannot achieve its true value.Just look what has happened this week,indeed first thing this morning.All those aspiring Warren Buffet’s thinking they were being very savvy , expecting to buy back at a much lower price.No doubt thinking there would be no news until April.
They have been caught out and can lament at leisure.
You call them ‘bone heads’ but this significant number of day traders are consistently undermining confidence in this share.They destroy any prospect of long term growth.Why would an institution invest only to see their investment walked down time and time again.
Look at LO who are sitting on a significant loss on the warrants that they exercised.
The CFO recognised that FUM is adversely affected by having such a large number of PI’s.
I don’t blame those who trade this share.Its a free market.
The only way this dilemma will be resolved is when a big pharma makes a bid.We are far nearer that conclusion with yesterdays news.
Please someone explain how the CFO is responsible for today’s share price.Today for example we had a very positive RNS: the result a 4% drop in the share price
Last year I listed all the very positive developments in this company’s history.The result a 40% drop in the share price since then.
It may well be the case that FUM could not raise other sources of finance and had to issue new shares,presumably to finance the USA efficacy trial.
In any normal scenario following the granting of FDA approval as the only over the counter treatment for erectile dysfunction this share would be 3 times its present price.
However the fundamental value is distorted by short term traders.
I think the only change will come about when the company is sold.The price will determine my profit after 15 years of frustration!!
I don’t agree with those heaping criticism on the CFO.It was not her that gave the disastrous interview after the interims.
What she did observe in an investor presentation was that there are too many PI’s holding shares in this company,this leads to the enormous volatility we witness constantly.
About 40% of the total shares are held by institutions.This leaves 60% in the hands of IP’s.
The catch 22 dilemma is that institutions cannot be persuaded to invest because of the volatility bought about by the 10% day traders.How to break this cycle is beyond my pay grade.
It is a sad fact that FUM in the last year has never been able to sustain a rally for more than about 5 days.
We LTH’s can only watch from the side lines in frustration as day traders make a few quid.
I still think that the Chinese failure still needs to play out(I think someone calculated that there may be some 2m shares to be offloaded)
Following this weeks RNS I am very confident that we LTH’s will be well rewarded.
It is clear from the wording of today’s RNS that the expectation is that the company will be bought out ,otherwise why reference the new none executive’s involvement in several successful takeovers.
Happy days.
I hate saying “I told you so” but if you look at my posts before Christmas I predicted this rally.
Read my post listing all of the positive news from earlier in the year .This is just too good to fail
I warned you that you were giving your shares away.
I told you so!
In July Lucy Tobin tipped FUM in her Sunday Times column.This Sunday she reviewed her tips to observe that FUM had gone down by 40%.
She did not analyse why.We all know it is because of JB’s disastrous interview after the interim results.
However Tobin has not lost faith in the share,she concludes by saying “the international rollout of its gel could yet see its share price perk up in 2024”
All of the signs are positive and as I have mentioned several times thoes who have sold out recently will watch with regret that they gave away their shares at these low prices.
I guarantee that all those punters who have sold in recent weeks ( many at a loss) will bitterly regret their decision.
I’m of the view that there may well be important developments,but the board have concluded that to make any announcements now will just get sold into and end up having no impact on the share price.
Just remember this : this will be the only ED treatment in the USA not needing a prescription,and before the FDA gave its approval Eroxon had to go through a 6 month efficacy trial.Plus the company has been granted a 30 year patent extension.
I think those selling out now will repent at leisure in the new year.
The transition at 14.04 is mine: it was a buy not a sale.How many more transactions are misleadingly reported? that lead to others selling?
In the last twelve months the following has happened.
Launch in Europe.
Uk launch in Uk Boots.
FDA approval.
Haleon partnership.
Commercialisation in Saudi Arabia
Patent extension 30 years.
Launch in United Emirates.
Marketing approval in Mexico.
Now available through out UK(not just Boots)
Available through Amazon.
Tipped by Sunday Times.
Boots product of year.
Despite all the above the share price is less than it was a year ago.
I fail to see how next year’s expenditure is more that it’s income (JB stupid observation that FUM will not be in profit until 2025)
I notice that share options in other companies is dependent on the share price not on the 3 directors awarding themselves options that has no respect for the share holder base.
Normally the share price is trashed straight after good news.It has taken a couple of days this time. I feel sorry for those investors who bought on Friday morning,only to now be sitting on significant losses.Is there still a persistent seller?If not what is the answer to encourage buyers?
Surely the BOD must address this situation.The share price has nearly halved in a few weeks. There has been no negative news in that time to justify this drop.
What struck me about today’s RNS is that there is over 300 million shares in issue .In relative terms a minuscule number of shares have been sold since the interim results,but it has had a devastating effect on the share price.
The cancellation had nothing to do with trade.As I understand it High Co were to navigate the obtaining of regulatory approval and establishing a market .Selling in China was not anticipated for a number of years.High Co were given very favourable share purchase/loan note/warrant exercise terms.
Depending on when they have sold/selling they will have been very well rewarded for failure!
I noticed in the interims that FUM stated that they had “recently “ terminated their contract with High Co ( another failed relationship negotiated by JB)We don’t know how recently. I think FUM tried to bury this development.It surely justified a stand alone RNS before the interims.
Be that as it is.
I still think that High Co have been selling since the cancellation of the contract.Is it possible that there was a term of the original agreement that they would not trade the shares during the currency of the contract,subject to a release clause?
If my theory is correct we will just have to wait for the completion of the offload.
The share price has no relation to the very positive news over recent months.
Thoughts!
Hands up my error misunderstanding about share price in March 2001.Not actually sure what it was.